Physiology of appetite and weight Flashcards

1
Q

BMI

  • Calculation
  • Underweight
  • Normal
  • Overweight
  • Obese
  • Morbidly obese
A

Calculation: Kg/ m2

Underweight: <18.5

Normal: 18.5-24.9

Overweight: 25-29.9

Obese: 30-39.9

Morbidly obese: >/= 40

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Methods of measuring weight/ body composition

A

BMI

Waist circumference

Skin fold test

Bioethical impedance analysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Metabolic syndrome

A

A group of symptoms/ signs associated with high risk of cardiovascular disease.
- Insulin resistance being the underlying factor.

Visceral obesity- central body fat
Dyslipidaemia
Hyperglycaemia
Hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Epidemiology of obesity

A

Prevalence is increasing.

- 25% in England [2010-2013]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Mechanism behind insulin resistance and metabolic syndrome.

A

An increase in free fatty acids causes dyslipidemia

  • Visceral fat lipolysis
  • Increase in gluconeogenesis

Increase in pro-inflammatory cytokines

  • TNF-alpha, IL-6 from white adipose tissue
  • Decreases the expression of GLUT-4 and tyrosine kinase activity of insulin receptor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Adipocytokines

A

White adipose tissue can release a lot of pro-inflammatory cytokines
- Such as IL-6, TNF-alpha

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Risk factors of Type 2 DM

A

Age
Obesity
Family history
Ethnicity [i.e south asian]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CVD associated with obesity

A

Stroke
Coronary heart disease
Hypertension
Left ventricular hypertrophy

Effects of obesity on the CVS

  • Increased blood volume
  • Increased blood viscosity
  • Increased vascular resistance.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Respiratory consequences of obesity

A

Obstructive sleep apnoea

Hypoxia/ Hypercapnia

Pulmonary hypertension/ Right heart failure

Daytime somnolence—> Daytime accidents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

GI/ Liver consequences of Obesity

A
Progresison of:
Non-alcoholic fatty liver
Non-alcoholic steatohepatits
Cirrhosis
Portal hypertension
Heptocellular cancer

Gallstones

GORD- gastroesophageal reflux disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cancer and obesity

  • Prevalence
  • Examples
  • Mechanism
A

Increases risk of cancer significantly
- 10% of non-smoker cancer deaths related to obesity.

Common cancers included

  • Breast
  • Colon
  • Endometrial
  • Oesophageal
  • Gall bladder
  • Renal
  • Thyroid

Mechanism

  • Increase in insulin, IGF-1, oestrogen
  • Increase in adipocytokines
  • Reflux
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Consequences of obesity on the reproductive system

A

Polycystic ovarian syndrome

Male hypogonadism

Adverse pregnancy outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Consequences of obesity on the joints

A

Osteoarthritis

Gout

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Consequences of obesity on mental health

A

Depression

Eating disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Genetic causes of obesity

A

Obesity associated syndromes

  • Prader Willi
  • Bardet Biedl
  • Fragile X

Can also be polygenic

  • Susceptible genes
  • Inherited almost as similarly as height.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Stimulation of appetite

A

Arcuate nucleus- Lateral hypothalamus contains hunger/thirst centre.
- Can be inhibited by the satiety centre.

Activation of neurones by grehlin stimulates appetite [accelerator neurones]

  • Neuropeptide Y [NPY]
  • Agouti-related protein {AgRP]

AgRP can also block melanocortin receptors

Leptin acts on NPY to promote satiety.

17
Q

Ghrelin

A

Hormone released from the stomach before meals

  • Stimulates hunger
  • Acts on hypothalamic neurones NPY, AgRP
18
Q

Hormones that reduce appetite

A

CCK

GLP-1

Peptide YY [PPY]

  • All peptide released rapidly after a meal.
19
Q

Leptin

A

Hormone released from adipose tissue.
- Slow acting on arcuate receptors [NPY neurones]

Signals to the hypothalamus body fat %.

  • Acts on satiety centre
  • Negatively regulates fat mass by inhibiting hunger.
  • Increases basal metabolic rate if fat mass rises.

Also important for puberty and reproduction.

20
Q

Leptin mutations

A

Loss of genes encoding leptin or its receptors cause severe,, early onset obesity.

  • Lack of satiety.
  • Shown in Ob/ob mouse.

If receptors are fine but there is lack of leptin
- Administering leptin can reverse obesity. [shown with ob/ob mouse]

Leptin cannot be used to reverse obesity in human adults as they already have high levels of leptin.

21
Q

Insulin and body weight

A

Acts on the cortex and limbic system

  • Regulates bod weight by signalling body fat composition.
  • Decreases food intake.
22
Q

Brake neurones

A

Located in the arcuate nucleus
- ventromedial hypothalamus

Contains neurones that inhibit appetite

  • Alpha-melanocyte stimulate hormone [MSH]
  • POMC
  • CART

These neurones can inhibit NPY and AgRP

23
Q

Diet regulation for obesity

A

Eating 500-1000 cal energy deficient

Decrease portion size and snacking.

Eating more low energy dense foods

  • More fruit and veg
  • Less food high in sat fat and sugar.
24
Q

Physical activity modification and Obesity

A

Exercising 7 days a week
- 30 min intense or 1 hr low intensity

10,000 steps a day

25
Environmental factors and obesity
Dietary intake - Increase in energy intake - Increase in portion size - Cheaper cost of food. Decease in physical activity - Car ownership and Tv ownership show positive trend with obesity.
26
Targets for lifestyle modification
10% of weight loss - Continue until ideal weight is reached - 1-2 lbs/ 0.5-1kg loss a week Problems - 5-10% weight loss takes a year to achieve - Yo-yo dieting
27
Orlistat - Mechanism of action - Indications - Adverse effects
Action - Inhibits pancreatic and and gastric lipases - Prevents hydrolysis of TG into FFA and glycerol. - Prevents absorption of dietary fat. Indications - Obesity Adverse effects- associated with fat malabsorption - Loose/ liquid stools - Faecal urgency - Anal discharge - Fat-soluble vitamin deficiency [ADEK]
28
Problems with using pharmacological therapy in obesity
Only increases 5% weight loss by 3-4 fold. Weight gain occurs when treatment is stopped.
29
Laproscopic adjustable banding [Gastric banding]
Restrictive surgery - Reduces diameter of the stomach - Allows reduced dietary intake and improves satiety.
30
Roux-en-Y gastric bypass
Restrictive and malabsorptive surgery - Bypasses the duodenum into the jejunum and reduces stomach size - Alters gut hormones and bile acid flow - Improves satiety Complications - Micronutrient deficiences - Dumping syndrome
31
Advantages of bariatric surgery
Significant weight loss - 25-30% Resolves/ Improves co-morbities - Cost effective in the long term.
32
Disadvantages of bariatric surgery
Perioperative mortality/ morbidity Long term follow-up - Micronutrient deficiencies Weight regain Expensive
33
Bariatric surgery guidelines | NICE
For T2 DM recent onset - Proceed if BMI > 35 - Consider if BMI >30 For obese, after failure of other options - First line if BMI> 50 - BMI> 40 - BI> 35 with co-morbidities
34
Bariatric surgery guidelines | NHS England
Same as NICE but - Obese for at least 5 years - Must engage with non-surgical weight loss programme for 12-24 months
35
Metformin and obesity
Increases insulin sensitivity - Increases peripheral glucose uptake - Inhibits gluconeogenesis Prevents hyperglycaemia
36
Weight loss from lifestyle interventions
5-10%